124 cases have been added to the Ozempic MDL in the past month
Keywords: Ischemia-Reperfusion Injury, Lower extremity, BPC157, Oxidative Stress, Apoptosis, Inflammation INTRODUCTION Chronic non-communicable diseasesincluding cardiovascular, metabolic, renal, and oncologic conditionsare leading causes of global morbidity and mortality, with peripheral artery disease (PAD) representing a major contributor due to its progressive nature, high prevalence, and cardiovascular risk equivalence to coronary artery disease.13 PAD, most commonly caused by atherosclerotic obstruction of the lower extremity arteries, impairs oxygen and nutrient delivery, resulting in clinical manifestations ranging from intermittent claudication to critical limb-threatening ischemia.4,5 It affects more than 200 million individuals worldwide and constitutes a substantial global health burden.6,7 In advanced stages, revascularization via bypass surgery, endovascular intervention, or thromboembolectomy is often required.8,9 However, despite restoring perfusion, these procedures frequently ACCEPTED MANUSCRIPT ARTICLE IN PRESS ARTICLE IN PRESS trigger ischemiareperfusion (I/R) injury, in which reperfusion exacerbates oxidative stress, inflammation, endothelial dysfunction, and cell death, ultimately compromising therapeutic outcomes.1013 I/R injury is not merely the consequence of the initial ischemic insult but arises from a complex cascade of biochemical and inflammatory processes triggered upon restoration of oxygenated blood flow
However, medication is just one element of a healthy lifestyle, and the fitness industry is taking advantage of the GLP-1 craze to promote products that work in conjunction with the medications to help people achieve better and lasting results
Once several metastases have formed, cells from each metastasis continue to seed and reseed other tumours, adding considerable complexity to the diversity of metastatic clones
